| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,501 |
4,639 |
$283K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,322 |
1,229 |
$85K |
| 90837 |
Psychotherapy, 53 minutes with patient |
202 |
155 |
$25K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,160 |
880 |
$14K |
| 90834 |
Psychotherapy, 45 minutes with patient |
51 |
36 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
95 |
87 |
$3K |
| 99000 |
|
1,178 |
1,033 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
102 |
95 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
766 |
670 |
$1K |
| 87428 |
|
30 |
28 |
$959.93 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
47 |
44 |
$573.78 |
| 90686 |
|
32 |
32 |
$453.57 |
| 90756 |
|
82 |
77 |
$412.87 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
13 |
$380.83 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19 |
17 |
$327.11 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
73 |
72 |
$208.30 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
14 |
12 |
$28.98 |
| 99173 |
|
12 |
12 |
$19.76 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13 |
13 |
$11.00 |